Positive Outlooks Blog

News and stories that make you feel better after reading.

  • Home
  • About Us
  • Stories
    • Travel
    • Health
    • Reflections
    • Quotes
  • Submit Your Story
  • Contact Us
  • Home
  • Janssen Pharmaceuticals

Nasal spray could help those who have no success with available depression treatments

Recently, the U.S. FDA approved esketamine, a fast-acting drug derived from the anesthetic, ketamine, that is intended to aid the treatment-resistant population of people with depression. There are about 16.2 million Americans who suffer from major depression, and as many as a quarter of them reported achieving little to no results from available treatments, including FDA

Read more →

Tagged with 
depression esketamine health Janssen Pharmaceuticals Johnson & Johnson ketamine medical treatment medicines pharmaceutical innovation science Spravato
 




Archives
Join Our Mailing List

We will send our inspiring stories straight to your inbox. PLEASE remember that you can manage your subscription by weekly, daily or once in a day. You are in control how you receive our stories.

Join 35,604 other subscribers

Advertisements
Collection of quotes that offer wisdom and hope:
Our Top Stories:
Country singers love this classic song, Lukas Nelson's version goes viral
Best friends of 78 years move into the same elderly care home together
Five students helped woman make it to her dialysis treatment
5-year-old boy invites entire kindergarten class to witness his adoption hearing
Rare kitten born with rare 'Two-Face' has grown up into a strikingly beautiful cat
Photo of police officer comforting a dog that was hit by car goes viral




Privacy Policy of Positive Outlooks